Atara Biotherapeutics (AT20.F) Q2 2026 Earnings

May 12Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-1.77
-0.14
1.5
3.13

Details

Expected EPS
-0.28075882067
Actual EPS
-0.2470771
Surprise EPS
0.03
Surprise Percent
+12%

Description

⁨Atara Biotherapeutics⁩ (⁦AT20.F⁩) has reported earnings of ⁦-0.2470771⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts